General Updates - IOL Chemicals and Pharmaceuticals LimitedNSE · exchange filing · pdf
Source filing Company dossier
IOL Chemicals & Pharmaceuticals
NSE:IOLCP · ISIN INE485C01029
- Close
- Unavailable Date unavailable
- Daily change
- N/A Exchange close
- Evidence state
- Building 0/0 checks
IOL Chemicals & Pharmaceuticals
Filings
Preserved evidence
40 recent eventsPrimary-source filing timeline
IOL Chemicals & Pharmaceuticals Ltd - 524164 - Approval From NMPA, China For Clopidogrel Bisulfate APIBSE · exchange filing · pdf
Source filing Certificate under SEBI (Depositories and Participants) Regulations, 2018 - IOL Chemicals and Pharmaceuticals LimitedNSE · exchange filing · pdf
Source filing IOL Chemicals & Pharmaceuticals Ltd - 524164 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018BSE · exchange filing · pdf
Source filing Credit Rating - IOL Chemicals and Pharmaceuticals LimitedNSE · credit rating · pdf
Source filing IOL Chemicals & Pharmaceuticals Ltd - 524164 - Announcement under Regulation 30 (LODR)-Credit RatingBSE · credit rating · pdf
Archived filing IOL Chemicals & Pharmaceuticals Ltd - 524164 - Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011BSE · exchange filing · pdf
Source filing Trading Window - IOL Chemicals and Pharmaceuticals LimitedNSE · exchange filing · pdf
Source filing IOL Chemicals & Pharmaceuticals Ltd - 524164 - Closure of Trading WindowBSE · exchange filing · pdf
Source filing Copy of Newspaper Publication - IOL Chemicals and Pharmaceuticals LimitedNSE · exchange filing · pdf
Source filing IOL Chemicals & Pharmaceuticals Ltd - 524164 - Announcement under Regulation 30 (LODR)-Newspaper PublicationBSE · exchange filing · pdf
Source filing General Updates - IOL Chemicals and Pharmaceuticals LimitedNSE · exchange filing · pdf
Source filing IOL Chemicals & Pharmaceuticals Ltd - 524164 - Communication To Shareholders Relating To Unclaimed DividendBSE · corporate action · pdf
Source filing General Updates - IOL Chemicals and Pharmaceuticals LimitedNSE · exchange filing · pdf
Source filing IOL Chemicals & Pharmaceuticals Ltd - 524164 - Disclosure Under Regulation 30 Of The Securities And Exchange Board Of India (Listing Obligations And Disclosure Requirements) Regulations, 2015BSE · exchange filing · pdf
Source filing Disclosure under SEBI Takeover Regulations - IOL Chemicals and Pharmaceuticals LimitedNSE · exchange filing · pdf
Source filing IOL Chemicals & Pharmaceuticals Ltd - 524164 - Announcement under Regulation 30 (LODR)-Earnings Call TranscriptBSE · conference call · pdf
Source filing Analysts/Institutional Investor Meet/Con. Call Updates - IOL Chemicals and Pharmaceuticals LimitedNSE · conference call · pdf
Source filing IOL Chemicals & Pharmaceuticals Ltd - 524164 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome — recordingBSE · conference call recording · other
Source filing IOL Chemicals & Pharmaceuticals Ltd - 524164 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationBSE · exchange filing · pdf
Source filing IOL Chemicals & Pharmaceuticals Ltd - 524164 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - OutcomeBSE · conference call · pdf
Source filing Analysts/Institutional Investor Meet/Con. Call Updates - IOL Chemicals and Pharmaceuticals LimitedNSE · conference call · pdf
Source filing Analysts/Institutional Investor Meet/Con. Call Updates - IOL Chemicals and Pharmaceuticals LimitedNSE · conference call · pdf
Source filing IOL Chemicals & Pharmaceuticals Ltd - 524164 - Announcement under Regulation 30 (LODR)-Investor PresentationBSE · investor presentation · pdf
Source filing IOL Chemicals & Pharmaceuticals Ltd - 524164 - Announcement under Regulation 30 (LODR)-Newspaper PublicationBSE · exchange filing · pdf
Source filing Copy of Newspaper Publication - IOL Chemicals and Pharmaceuticals LimitedNSE · exchange filing · pdf
Source filing Investor Presentation - IOL Chemicals and Pharmaceuticals LimitedNSE · investor presentation · pdf
Source filing IOL Chemicals & Pharmaceuticals Ltd - 524164 - Announcement under Regulation 30 (LODR)-Press Release / Media ReleaseBSE · financial results · pdf
Source filing IOL Chemicals & Pharmaceuticals Ltd - 524164 - Compliances-Reg.24(A)-Annual Secretarial ComplianceBSE · exchange filing · pdf
Source filing IOL Chemicals & Pharmaceuticals Ltd - 524164 - Fixed 39Th Annual General Meeting Of The Company And Book Closure Of Register Of MembersBSE · exchange filing · pdf
Source filing IOL Chemicals & Pharmaceuticals Ltd - 524164 - Board Meeting Outcome for Outcome Of The Board Meeting And Submission Of Audited Financial Results For The Quarter And Year Ended 31St March 2026BSE · financial results · pdf
Source filing IOL Chemicals & Pharmaceuticals Ltd - 524164 - Outcome Of The Board Meeting And Submission Of Audited Financial Results For The Quarter And Year Ended 31St March 2026BSE · financial results · pdf
Source filing IOL Chemicals & Pharmaceuticals Ltd - 524164 - Comments Of Board Of DirectorsBSE · exchange filing · pdf
Source filing Outcome of Board Meeting - IOL Chemicals and Pharmaceuticals LimitedNSE · financial results · pdf
Source filing Press Release - IOL Chemicals and Pharmaceuticals LimitedNSE · financial results · pdf
Source filing General Updates - IOL Chemicals and Pharmaceuticals LimitedNSE · exchange filing · pdf
Source filing IOL Chemicals & Pharmaceuticals Ltd - 524164 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationBSE · conference call · pdf
Source filing Analysts/Institutional Investor Meet/Con. Call Updates - IOL Chemicals and Pharmaceuticals LimitedNSE · conference call · pdf
Source filing IOL Chemicals & Pharmaceuticals Ltd - 524164 - Board Meeting Intimation for Notice Of The Board MeetingBSE · exchange filing · pdf
Source filing Spurt in Volume - IOL Chemicals and Pharmaceuticals LimitedNSE · exchange filing · pdf
Source filing